Search clinical trials for: IL-17/IL-22 autoantibodies from thymoma

Total 41508 results

McMaster University
Sanofi

Not yet recruiting

IL-13 Blockade and Airway Autoimmunity in Asthma (IL-SAA)

Airway Auto Immunity in Asthma
Creighton University
Novartis Pharmaceuticals

Completed

The Effect of Xolair (Omalizumab) on Allergy Blood Cells

Asthma

United States
Renovo

Completed

Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)

Cicatrix | Wound Healing

United Kingdom
Uppsala County Council, Sweden

Recruiting

Intestinal Lavage to Promote Enteral Feeding and Prevent Necrotizing Enterocolitis in Extremely Preterm Infants

Necrotizing Enterocolitis | Time to Full Enteral Nutrition

Sweden
Hamamatsu University
Yokoyama Foundation for Clinical Pharmacology

Unknown

Cytokine Gene Polymorphisms in Gastric Diseases

Gastric Cancer | Gastric Ulcer | Duodenal Ulcer

Japan
VA Office of Research and Development

Withdrawn

Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis (PACT CREATE 3)

Breast Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Lung Cancer | Bladder Cancer

United States
Il-Yang Pharm. Co., Ltd.

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Peptic Ulcer

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Not yet recruiting

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Pharmacokinetics

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease

Parkinson Disease

France
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Pharmacokinetics

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

Drug Interaction Potentiation

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

Gastric Cancer

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

Influenza, Human

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Philadelphia Chromosome

India, Korea, Republic of, Thailand
Il-Yang Pharm. Co., Ltd.

Unknown

A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients

Helicobacter Pylori Infection

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

Bone Marrow Diseases | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Philadelphia Chromosome

Korea, Republic of, Indonesia, Thailand, Philippines
Il-Yang Pharm. Co., Ltd.

Completed

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults

Healthy

Korea, Republic of
Eli Lilly and Company

Completed

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Puerto Rico, United States, Germany, Poland, Japan, Canada
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Completed

Tocilizumab (TCZ) in New-onset Type 1 Diabetes (EXTEND)

Type 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes Mellitus

United States, Australia
Neumedicines Inc.
Department of Health and Human Services

Completed

Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure

Hematopoietic Syndrome Due to Acute Radiation Syndrome

United States
University of Messina

Completed

Evaluation of Saliva IL-6 Levels and Periodontitis

Periodontal Diseases

Italy
The First Affiliated Hospital with Nanjing Medical...
Baxter Healthcare Corporation

Unknown

Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition

Nutritional Supplement Toxicity

China
Pfizer

Completed

A Preliminary Study to Evaluate PF-07264660 in Healthy Participants

Healthy

United States
Cairo University

Unknown

Assessing LncRNA DQ786243 and IL-17 Expression in Oral Lichen Planus: A Case Control Study

Patients With Oral Lichen Planus

Egypt
Ain Shams University

Recruiting

Chronic Unilateral Lumbar Radicular Pain

Neuropathic Pain

Egypt
Assistance Publique - Hôpitaux de Paris
Iltoo Pharma

Completed

Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers (HEALTHIL-2)

Healthy Volunteers

France
Charite University, Berlin, Germany
German Research Foundation; adexter GmbH

Completed

Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)

Septicemia

Germany
Eli Lilly and Company

Active, not recruiting

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

Ulcerative Colitis

Spain, United States, China, Australia, Austria, Japan, Hungary, Taiwan, Russian Federation, Canada, Korea, Republic of, Italy, Belgium, Poland, Switzerland, Argentina, India, Israel, Latvia, Ukraine, Denmark, Mexico, Romania, Malaysia, Netherland... and more
Alexandria University

Recruiting

Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study (ME)

Myalgic Encephalomyelitis

Egypt
Pieris Australia Pty Ltd

Completed

Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

Healthy Subjects

Australia
Samsung Medical Center

Recruiting

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Hepatocellular Carcinoma | Portal Vein Thrombosis

Korea, Republic of
Novartis Pharmaceuticals

Terminated

A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers

Metastatic and Advanced Solid Tumors

United States
Margaret Ragni
Wyeth is now a wholly owned subsidiary of Pfizer; University of North Carolina

Completed

IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia

Von Willebrand Disease

United States
Chulalongkorn University
King Chulalongkorn Memorial Hospital

Recruiting

Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG (CMD03DIPG)

Diffuse Intrinsic Pontine Glioma | DIPG Brain Tumor

Thailand
Keymed Biosciences Co.Ltd

Recruiting

The Study of CM310 in Patients With Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

China
Mayo Clinic
American Heart Association

Active, not recruiting

Neural Circulatory Control and SUDEP Risk. (NC-SUDEP)

Epilepsy | Seizures

United States
Xalud Therapeutics, Inc.

Terminated

Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain

Neuropathic Pain

Australia
Medical University of Vienna
Charite University, Berlin, Germany; University of Alberta; CSL Behring

Completed

A Pilot Trial of Clazakizumab in Late ABMR

Antibody-mediated Rejection

Austria, Germany
Peking University People's Hospital
Monash University

Completed

Low-dose IL-2( Interleukin-2) Treatment in SLE

Systemic Lupus Erythematosus

China
University of Pennsylvania
Drexel University

Completed

PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection

HIV Infection

United States
Aerovance, Inc.

Completed

Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics

Allergic Asthma

United Kingdom
Yale University
Lilly PharmaceuticalCompany

Not yet recruiting

Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis

Idiopathic Subglottic Stenosis

United States
Peking University People's Hospital

Completed

Anti-infection of Low-does IL-2 in SLE

Systemic Lupus Erythematosus

China
IRCCS San Raffaele

Completed

Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression (MICRO-MM)

Multiple Myeloma

Italy
Centre Leon Berard

Completed

Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection (IMMUNONCOVID)

SARS-CoV-2 (COVID-19) Infection | Advanced or Metastatic Hematological or Solid Tumor

France
University of the Pacific

Recruiting

Effects of Invisalign Palatal Expander System

Palatal Expansion Technique

United States
Cairo University

Not yet recruiting

Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides

Mycosis Fungoides

Egypt
Revimmune
Washington University School of Medicine; Vanderbilt University School of Medicine

Completed

A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients (IRIS-7-B)

Severe Sepsis With Septic Shock

United States
Neumedicines Inc.
Department of Health and Human Services

Completed

Safety Study of HemaMax™ (rHuIL-12) to Treat Acute Radiation Syndrome

Hematopoietic Syndrome Due to Acute Radiation Syndrome

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

Rhabdomyosarcoma | Ewing's Sarcoma

United States

Search clinical trials for: IL-17/IL-22 autoantibodies from thymoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations